| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 02/17/2005 | WO2004044226A3 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 02/17/2005 | WO2004031402A3 Methylation profile of cancer |
| 02/17/2005 | US20050039224 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 02/17/2005 | US20050037204 Aligned perpendicular to substrate; chemical vapor deposition; heavy pressure pretreatment improves thermoconductivity; Langmuir-Blodgett process |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/10/2005 | WO2005012553A2 Optical in vivo probe of analyte concentration within the sterile matrix under the human nail |
| 02/10/2005 | WO2005012551A2 Interaction of nmda receptor with protein tyrosine phosphatase |
| 02/10/2005 | WO2005012549A2 Apparatus and methods for evaluating the barrier properties of a membrane |
| 02/10/2005 | WO2005012546A2 Methods for isolating and identifying novel target-specific structuremers for use in the biological sciences |
| 02/10/2005 | WO2005012545A2 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors |
| 02/10/2005 | WO2005012544A2 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics |
| 02/10/2005 | WO2005012543A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 02/10/2005 | WO2004092397A3 Tmprss2 regulatory sequences and uses thereof |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032033 Glyphosate-resistant 5-enolpyruvylshikimate-3-phosphate synthase markers; high throughput assay; kits |
| 02/10/2005 | US20050031616 Controlled platelet activation to monitor therapy of ADP antagonists |
| 02/10/2005 | CA2534359A1 Apparatus and methods for evaluating the barrier properties of a membrane |
| 02/10/2005 | CA2533600A1 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 02/03/2005 | WO2005010204A2 Rapid nucleic acid isolation method and compositions therefore |
| 02/03/2005 | WO2005010202A2 PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS |
| 02/03/2005 | WO2005010201A2 Methods and compositions for detecting nucleic acid sequences |
| 02/03/2005 | WO2005010200A2 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
| 02/03/2005 | WO2005010199A2 Invasive cleavage reaction with electrochemical readout |
| 02/03/2005 | WO2005010197A2 A systemic small rna signaling system in plants |
| 02/03/2005 | WO2004102195A8 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/03/2005 | WO2004101808A3 Genomic and proteomic approaches for the development of cell culture medium |
| 02/03/2005 | WO2004055200A3 Methods for screening compounds for use in the treatment of disease |
| 01/27/2005 | WO2005007878A2 Method of modulating apoptosis and compositions thereof |
| 01/27/2005 | WO2005007877A2 Regulatable promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007875A2 Enhanced promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007874A2 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | WO2005007872A2 Detection of a target in a preservative solution |
| 01/27/2005 | WO2005007871A2 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | WO2005007870A2 COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF |
| 01/27/2005 | WO2005007869A2 Assays for the direct measurement of gene dosage |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007866A2 Biochip devices for ion transport measurement, methods of manufacture, and methods of use |
| 01/27/2005 | WO2004081222A3 Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
| 01/27/2005 | US20050019884 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 01/27/2005 | US20050019778 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | CA2531571A1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | CA2531002A1 Detection of a centrosomal target in an alcoholic preservative solution |
| 01/27/2005 | CA2527660A1 Biochip devices for ion transport measurement, methods of manufacture, and methods of use |
| 01/26/2005 | EP1499738A2 Recombinase polymerase amplification |
| 01/20/2005 | WO2005005653A2 Crystallization reagent matrices and related methods and kits |
| 01/20/2005 | WO2005005652A2 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants |
| 01/20/2005 | US20050014145 Using gross anatomical features and cationic dye staining of head, neck and saliva tissues as indicator tools in the detection cell proliferative disorders |
| 01/19/2005 | EP1319179A4 Methods for detecting and assaying nucleic acid sequences |
| 01/19/2005 | EP1232282B1 Automated method for identifying related biomolecular sequences |
| 01/13/2005 | WO2005003386A2 Oligonucleotide ligation assay by detecting released pyrophosphate |
| 01/13/2005 | WO2005003376A2 Anthrax antigen vaccine cultures by fluorescence polarization |
| 01/13/2005 | WO2005003374A2 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES |
| 01/13/2005 | WO2005003372A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003371A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | WO2005003370A2 Methods for enhancing gene expression analysis |
| 01/13/2005 | WO2005003369A2 Methods for detection and quantification of analytes |
| 01/13/2005 | WO2005003303A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2004076680A3 Process and composition for inhibiting growth of microorganisms |
| 01/13/2005 | US20050009099 Determining and monitoring interactions between phage-displayed proteins and test molecules; drug screening; enzyme inhbitors |
| 01/13/2005 | US20050009052 Differential tag length analysis of cell proliferation |
| 01/13/2005 | CA2531412A1 Synthesis of .beta.-l-2'-deoxy nucleosides |
| 01/13/2005 | CA2529559A1 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | CA2528109A1 Methods for enhancing gene expression analysis |
| 01/13/2005 | CA2527908A1 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | CA2527905A1 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/12/2005 | EP1495307A2 Combinatorial synthesis system |
| 01/06/2005 | WO2005001113A2 Methods for detecting nucleic acid variations |
| 01/06/2005 | WO2005001112A2 RIBOSOMAL RNA METHYLTRANSFERASES R1mA: TARGET VALIDATION AND PROCESSES FOR DEVELOPING AN INHIBITOR ASSAY AND IDENTIFICATION CANDIDATE INHIBITORS |
| 01/06/2005 | WO2005001110A2 Transcriptional regulation of gene expression by small double-stranded modulatory rna |
| 01/06/2005 | WO2005001109A2 Methods and compositions to detect microbes in fecal samples |
| 01/06/2005 | US20050004026 Induction of capacse cascade ; administering apoptosis inducing protein; drug screening; anticancer agents |
| 01/06/2005 | US20050004005 Methods of treating diseases responsive to Induction of Apoptosis |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 12/30/2004 | US20040266954 For high rotation freedom of second-order nonlinear optical chromophores during the poling and relatively mild conditions for lattice hardening |
| 12/30/2004 | US20040265880 Genomic and proteomic approaches for the development of cell culture medium |
| 12/30/2004 | US20040265867 the Riley-Day syndrome; localization will permit prenatal diagnosis in affected families |
| 12/30/2004 | US20040265836 Methods for the identification of inhibitors of C4 Long Chain Base Hydroxylase activity in plants |
| 12/29/2004 | WO2004113556A2 Assay and kits for detecting protein binding |
| 12/29/2004 | WO2004113555A2 Identifying, monitoring, and sorting genetically modified plant portions |
| 12/29/2004 | WO2004113554A2 Methods for determining susceptibility to psoriasis |
| 12/29/2004 | WO2004113553A2 Method of producing pure amidites and oligonucleotides |
| 12/29/2004 | WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/29/2004 | WO2004113503A2 Mbms as modifiers of branching morphogenesis and methods of use |
| 12/29/2004 | WO2004042072A3 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 12/29/2004 | WO2004016803A3 Method of enhancing cd4+ t cell responses |
| 12/29/2004 | EP1490823A1 A method for gene mapping from genotype and phenotype data |
| 12/29/2004 | EP1490486A2 Method of identifying genes controlling diferentiation |
| 12/29/2004 | CN1558956A Light-directed molecular analysis for cancer prognosis and diagnosis |
| 12/23/2004 | WO2004111260A2 Immobilization of bead-displayed ligands on substrate surfaces |
| 12/23/2004 | WO2004111259A2 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 12/23/2004 | WO2004081221A3 Pre-incubation method to improve signal/noise ratio of nucleic acid assays |
| 12/23/2004 | WO2004076684A3 Compositions and methods for the detection of mammalian muscle troponin i |
| 12/23/2004 | WO2004072229A3 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 12/23/2004 | US20040258672 Graft acceptance through manipulation of thymic regeneration |
| 12/16/2004 | WO2004108948A2 Systems, methods and kits for characterizing phosphoproteomes |
| 12/16/2004 | WO2004108947A2 Biological terrain management |
| 12/16/2004 | WO2004108946A2 Crystals of herpes simplex virus 1 dna polymerase and/or herpes simplex virus 1 dna polymerase-like proteins and the use thereof |
| 12/16/2004 | WO2004108945A2 Oligonucleotide modulation of cell adhesion |
| 12/16/2004 | US20040253584 Method for separating nucleic acids into populations |
| 12/15/2004 | EP1485501A2 Method for generating amplified rna |